# Becton, Dickinson and Co. (BDX) insider trading

> In the 12 months to Nov 12, 2026, 5 BDX insiders reported open-market sales of $3.4M across 21 filings; no open-market purchases were filed.

Canonical: https://massive.com/quote/bdx/insider-trading
Latest filing: 2026-11-09 (last 12 months; source: SEC EDGAR)
Source: Massive (https://massive.com/docs/llms.txt)

## Summary

| Measure | Value | Detail |
| --- | --- | --- |
| Open-market sales | $3.4M | 21 filings · 5 insiders |
| Open-market purchases | $0 | 0 filings |
| Pre-arranged sales (10b5-1) | 19 of 21 | $2.8M of $3.4M sold (82%) |

## Open-market trades by insider

| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
| --- | --- | --- | --- | --- | --- | --- |
| Thomas E. Polen Jr. | Chairman, CEO and President | $1.8M | — | 3 | 100% of sales | 2026-11-09 |
| Michael David Garrison | EVP & Pres Med.Essntl&BioPharm | $784.2K | — | 4 | 100% of sales | 2026-06-25 |
| Roland Goette | EVP and President, EMEA | $440.9K | — | 1 | — | 2026-08-12 |
| Michael Feld | EVP, CRO & Pres. Life Sciences → EVP, Chief Revenue Officer | $175.3K | — | 12 | 100% of sales | 2026-10-27 |
| Bertram L. Scott | Director | $174.0K | — | 1 | — | 2026-02-18 |

## Open-market trades by filing

21 filings in the last 12 months, newest first.

| Filed | Traded | Insider | Role | Type | Shares | Avg price | Value | Held after | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 2026-11-09 | 2026-11-05 | Thomas E. Polen Jr. | Chairman, CEO and President | Sale (10b5-1) | 2,993 | $210.00 | $628.5K | 110,163 | — |
| 2026-10-27 | 2026-10-26 | Michael Feld | EVP, Chief Revenue Officer | Sale (10b5-1) | 76 | $198.13 | $15.1K | 19,568 | — |
| 2026-09-29 | 2026-09-28 | Michael Feld | EVP, Chief Revenue Officer | Sale (10b5-1) | 76 | $183.70 | $14.0K | 19,644 | — |
| 2026-08-27 | 2026-08-26 | Michael Feld | EVP, Chief Revenue Officer | Sale (10b5-1) | 165 | $188.49 | $31.1K | 19,720 | — |
| 2026-08-14 | 2026-08-13 | Thomas E. Polen Jr. | Chairman, CEO and President | Sale (10b5-1) | 4,152 | $185.00 | $768.1K | 110,163 | — |
| 2026-08-12 | 2026-08-11 | Roland Goette | EVP and President, EMEA | Sale | 2,438 | $180.84 | $440.9K | 14,856 | — |
| 2026-07-28 | 2026-07-27 | Michael Feld | EVP, Chief Revenue Officer | Sale (10b5-1) | 75 | $157.13 | $11.8K | 20,934 | — |
| 2026-06-26 | 2026-06-26 | Michael Feld | EVP, Chief Revenue Officer | Sale (10b5-1) | 75 | $152.80 | $11.5K | 21,009 | — |
| 2026-06-25 | 2026-06-24 | Michael David Garrison | EVP & Pres Med.Essntl&BioPharm | Sale (10b5-1) | 1,100 | $145.66 | $160.2K | 13,172 | — |
| 2026-06-11 | 2026-06-10 | Michael David Garrison | EVP & Pres Med.Essntl&BioPharm | Sale (10b5-1) | 1,100 | $151.48 | $166.6K | 14,272 | — |
| 2026-06-03 | 2026-06-01 | Thomas E. Polen Jr. | Chairman, CEO and President | Sale (10b5-1) | 2,764 | $146.35 | $404.5K | 110,163 | — |
| 2026-05-27 | 2026-05-26 | Michael Feld | EVP, Chief Revenue Officer | Sale (10b5-1) | 75 | $147.35 | $11.1K | 21,084 | — |
| 2026-04-28 | 2026-04-27 | Michael Feld | EVP, Chief Revenue Officer | Sale (10b5-1) | 74 | $151.94 | $11.2K | 21,159 | — |
| 2026-03-27 | 2026-03-26 | Michael Feld | EVP, Chief Revenue Officer | Sale (10b5-1) | 75 | $156.83 | $11.8K | 21,233 | — |
| 2026-02-27 | 2026-02-26 | Michael Feld | EVP, Chief Revenue Officer | Sale (10b5-1) | 75 | $181.84 | $13.6K | 21,308 | — |
| 2026-02-18 | 2026-02-18 | Bertram L. Scott | Director | Sale | 953 | $182.61 | $174.0K | 36,763 | — |
| 2026-01-28 | 2026-01-26 | Michael Feld | EVP, CRO & Pres. Life Sciences | Sale (10b5-1) | 75 | $202.73 | $15.2K | 16,431 | — |
| 2026-01-16 | 2026-01-15 | Michael David Garrison | EVP & Pres Med.Essntl&BioPharm | Sale (10b5-1) | 1,610 | $207.46 | $334.0K | 12,095 | — |
| 2025-12-29 | 2025-12-26 | Michael Feld | EVP, CRO & Pres. Life Sciences | Sale (10b5-1) | 74 | $196.08 | $14.5K | 16,506 | — |
| 2025-12-17 | 2025-12-17 | Michael David Garrison | EVP & Pres Med.Essntl&BioPharm | Sale (10b5-1) | 629 | $196.03 | $123.3K | 13,105 | — |
| 2025-12-02 | 2025-12-01 | Michael Feld | EVP, CRO & Pres. Life Sciences | Sale (10b5-1) | 75 | $193.36 | $14.5K | 16,580 | — |

## Other insider activity (not market trades)

- Option exercises: 4 records
- Tax withholding: 14 records
- Grants and awards: 36 records
- Other: 4 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

## How to read this page

- **Open-market purchase or sale**: A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- **Pre-arranged (10b5-1)**: The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- **Role**: The title on each filing. Someone whose title changed shows more than one.
- **Filing date**: Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.

## FAQ

### Has Becton, Dickinson and Co.'s CEO sold stock?

Yes. Thomas E. Polen Jr. (CEO) sold 9,909 shares ($1.8M) between Jun 2026 and Nov 2026, all under a pre-arranged 10b5-1 plan.

### How current is BDX’s insider data?

These are BDX Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

### What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

## Live data

This page joins two Massive endpoints: Form 4 filings and daily prices. The BDX Form 4 request:

- `GET https://api.massive.com/stocks/filings/vX/form-4?tickers=BDX&filing_date.gte=2025-11-12&sort=filing_date.desc&limit=500`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Becton, Dickinson and Co. (BDX) stock price](https://massive.com/quote/bdx.md)
- [Recent insider trading](https://massive.com/quote/insider-trading.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms